FC

Adimab Announces Successful Resolution of Lawsuit Brought Against LinkedUp Bioscience and Tianti Biotherapeutics

Retrieved on: 
Thursday, December 21, 2023

In return for undisclosed consideration to Adimab, Adimab has withdrawn its claims that the LinkedUp parties misappropriated Adimab technology or breached any confidentiality agreement, and the LinkedUp parties shall have the unfettered right to continue using their technology as it exists today.

Key Points: 
  • In return for undisclosed consideration to Adimab, Adimab has withdrawn its claims that the LinkedUp parties misappropriated Adimab technology or breached any confidentiality agreement, and the LinkedUp parties shall have the unfettered right to continue using their technology as it exists today.
  • Similarly, LinkedUp and its related parties have withdrawn their counterclaims, including unfair and deceptive trade practices, intentional interference with business relationships, and infliction of emotional distress.
  • Our partners know that we bring unique technology and expertise to our efforts,” added Philip T. Chase, Chief Executive Officer of Adimab.
  • Bispecifics and T-cell engagers: Adimab has extensive bispecific and multispecific capabilities, including common light chain and fragment-based discovery and engineering.

Franklin Covey to Report First Quarter Fiscal 2024 Results

Retrieved on: 
Wednesday, December 20, 2023

Franklin Covey Co. (NYSE: FC), a leader in organizational performance improvement, announced today that the conference call to review the Company’s first quarter fiscal 2024 financial results will take place on Thursday, January 4, 2024, at 5:00 p.m.

Key Points: 
  • Franklin Covey Co. (NYSE: FC), a leader in organizational performance improvement, announced today that the conference call to review the Company’s first quarter fiscal 2024 financial results will take place on Thursday, January 4, 2024, at 5:00 p.m.
  • The Company’s financial results are expected to be released after the close of the market on Thursday, January 4, 2024.
  • Interested persons may access a live webcast at https://edge.media-server.com/mmc/p/r2a3rane or may participate via telephone by registering at https://register.vevent.com/register/BI4da7714a312d4847a54f00840f328fd4 .
  • A replay of the conference call webcast will be archived on the Company’s website for at least 30 days.

Wedbush Securities Welcomes Rebecca Hern as Managing Director, Investments

Retrieved on: 
Wednesday, December 20, 2023

Wedbush Securities , a prominent diversified independent financial services provider, welcomes Rebecca Hern as Managing Director, Investments and Financial Consultant in Charge.

Key Points: 
  • Wedbush Securities , a prominent diversified independent financial services provider, welcomes Rebecca Hern as Managing Director, Investments and Financial Consultant in Charge.
  • Hern rejoins her home state of Dallas, TX and will run the firm’s budding footprint and growth in the greater Dallas area.
  • View the full release here: https://www.businesswire.com/news/home/20231220209534/en/
    Rebecca Hern, MD, Investments and FC in Charge, Wedbush Securities, Dallas, TX (Photo: Business Wire)
    Specializing in serving divorced or widowed women and having a unique background as a former personal banker, Hern says, “Joining Wedbush is a natural evolution for me, offering flexibility to deliver exemplary service while enjoying the benefits of working in my hometown.
  • Returning to the area from Lexington, KY, Hern has firmly rooted herself in Dallas, which she proudly calls home.

TAE Life Sciences to Present Groundbreaking Developments in Cancer Drug Development at Biotech Showcase 2024

Retrieved on: 
Wednesday, December 27, 2023

SAN FRANCISCO, Dec. 27, 2023 /PRNewswire/ -- At the forefront of pioneering advancements in the field of radiation oncology, TAE Life Sciences is set to unveil significant strides in its innovative drug development at the esteemed Biotech Showcase, taking place in parallel to the 42nd annual J.P. Morgan Healthcare Conference (JPM).

Key Points: 
  • At the event, Rob Hill, Chief Executive Officer of TAE Life Sciences, will unveil groundbreaking insights derived from recent studies on BTS, the company's proprietary boronated drug designed for Boron Neutron Capture Therapy (BNCT).
  • This development holds significant promise for BNCT—a highly precise and targeted radiation therapy applicable to various cancer types.
  • Details about Rob Hill's presentation at Biotech Showcase 2024:
    TAE Life Sciences invites interested stakeholders and investors to attend Rob's presentation to gain deeper insights into these transformative developments and explore potential collaborations.
  • For more information about TAE Life Sciences, BTS, engineered antibody drugs, and Alphabeam BNCT system, please visit www.taelifesciences.com .

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 9, 2023

WALTHAM, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced pipeline progress and business updates and reported financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Xilio anticipates activating clinical trial sites for the Phase 1 combination dose escalation in the fourth quarter of 2023.
  • As previously announced, Xilio anticipates reporting preliminary safety data from the Phase 1 clinical trial into the third dose level in the fourth quarter of 2023.
  • General & Administrative (G&A) Expenses: G&A expenses were $6.3 million for the quarter ended September 30, 2023, compared to $7.2 million for the quarter ended September 30, 2022.
  • Net Loss: Net loss was $16.7 million for the quarter ended September 30, 2023, compared to $19.8 million for the quarter ended September 30, 2022.

Chicago Fire FC and Phoenix Rising FC Join Coachella Valley Invitational Set to Take Place Feb. 4-17, 2024, at Empire Polo Club in Indio, Calif.

Retrieved on: 
Wednesday, December 6, 2023

Chicago Fire FC and Phoenix Rising FC (USL) will become the 11th and 12th clubs confirmed to participate in the 2024 Coachella Valley Invitational (CVI), it was announced today by event organizers AEG, the world’s leading sports and live entertainment company.

Key Points: 
  • Chicago Fire FC and Phoenix Rising FC (USL) will become the 11th and 12th clubs confirmed to participate in the 2024 Coachella Valley Invitational (CVI), it was announced today by event organizers AEG, the world’s leading sports and live entertainment company.
  • Additionally, beginning Thursday, Dec. 7 at 10:00 a.m. PT, passes for all matches will go on-sale to the public at CoachellaValleyInvitational.com.
  • The initial schedule of matches taking place at Empire Polo Club in Indio, Calif. was also revealed today and is listed below.
  • LA Galaxy vs. Charlotte FC at 11:00 a.m. PT
    New York City FC vs. San Jose Earthquakes at 12:00 p.m. PT
    Austin FC vs. Chicago Fire FC at 1:00 p.m. PT
    Charlotte FC vs. San Jose Earthquakes at 11:00 a.m. PT
    Minnesota United FC vs. Phoenix Rising FC at 12:00 p.m. PT
    Portland Timbers vs. New York City FC at 1:00 p.m. PT
    LA Galaxy vs. Austin FC at 10:00 a.m. PT
    LAFC vs. Chicago Fire FC at 12:30 p.m. PT
    Portland Timbers vs. San Jose Earthquakes at 11:00 a.m. PT
    LA Galaxy vs. New York City FC at 12:00 p.m. PT
    Austin FC vs. New York Red Bulls at 1:00 p.m. PT
    Minnesota United FC vs. Chicago Fire FC at 2:00 p.m. PT
    LA Galaxy vs. New York Red Bulls at 10:00 a.m. PT
    Minnesota United FC vs. Charlotte FC at 10:00 a.m. PT
    Portland Timbers vs. Chicago Fire FC at 12:00 p.m. PT
    The current list of participating teams include:

Austin FC and Q2 Announce the 2023 “Q-mmunity Gives” Grant Recipients; $150,000 Awarded to Local Nonprofits

Retrieved on: 
Monday, December 4, 2023

Austin FC and Q2 Holdings Inc. today announced the three recipients of the 2023 Q-mmunity Gives grant program.

Key Points: 
  • Austin FC and Q2 Holdings Inc. today announced the three recipients of the 2023 Q-mmunity Gives grant program.
  • Local nonprofit organizations CareBOX Program, Health Alliance for Austin Musicians (HAAM) and Seedling Foundation will each receive a $50,000 grant to focus on advancing underrepresented communities in Central Texas.
  • “Austin is home to a thriving nonprofit community,” said Austin FC President Andy Loughnane.
  • The Q-mmunity Gives grant program, funded and presented by Austin FC and Q2, will continue to award Q-mmunity Gives grants annually.

UEFA EURO 2024™ Comes to EA SPORTS FC™ 24, EA SPORTS FC Mobile, and EA SPORTS FC Online in Summer 2024

Retrieved on: 
Thursday, November 23, 2023

For more information on the exclusive UEFA EURO 2024 holiday offer available to players across EA SPORTS FC 24 and EA SPORTS FC Mobile, visit EA.com .

Key Points: 
  • For more information on the exclusive UEFA EURO 2024 holiday offer available to players across EA SPORTS FC 24 and EA SPORTS FC Mobile, visit EA.com .
  • “We’re delighted to announce that one of next summer’s biggest football tournaments will be fully integrated across EA SPORTS FC titles,” said David Jackson, Vice President of Brand for EA SPORTS FC.
  • EA SPORTS FC ™ 24 is available now for PlayStation®5, Xbox Series X|S, PC, PlayStation 4, Xbox One, and Nintendo Switch™.
  • Download EA SPORTS FC Mobile on the App Store and Google Play Store to access the World’s Game in Your Pocket.

Nexon Releases Earnings for Third Quarter 2023

Retrieved on: 
Thursday, November 9, 2023

NEXON Co., Ltd. (Nexon) (3659.TO), a global leader in Virtual Worlds, today announced financial results for its third quarter ended on September 30, 2023.

Key Points: 
  • NEXON Co., Ltd. (Nexon) (3659.TO), a global leader in Virtual Worlds, today announced financial results for its third quarter ended on September 30, 2023.
  • “Nexon is tracking to finish the year with seven consecutive quarters of double-digit revenue growth,” said Owen Mahoney, President and CEO of Nexon.
  • For our investors, this translates to an asymmetric upside opportunity with existing franchises delivering steady revenue and new releases offering potential for step-function growth.
  • While packaged sales of digital items increased year over year, sales of individual items decreased as Nexon ramped up award incentives to attract players.

Advanced Semiconductor Packaging Market Size Worth USD 40.3 billion, at a CAGR of 5.2% by 2031 - Transparency Market Research, Inc.

Retrieved on: 
Thursday, December 14, 2023

WILMINGTON, Del., Dec. 14, 2023 /PRNewswire/ -- The global advanced semiconductor packaging market was projected to attain US$ 30.1 billion in 2022. It is anticipated to garner a 5.2% CAGR from 2023 to 2031. By 2031, the market is likely to attain a valuation of US$ 40.3 billion by 2031.

Key Points: 
  • Advanced semiconductor packaging is becoming more and more in demand as consumer electronics consumption rises.
  • The increasing demand for smartphones, household appliances, and wearable technology among consumers is driving up the need for sophisticated semiconductor packaging.
  • Consumers are choosing more sophisticated IoT devices, which is anticipated to accelerate the growth of the advanced semiconductor packaging market shortly.
  • Ask Expert for the Research Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&re...
    Global Market for Advanced Semiconductor Packaging: Regional Outlook
    Various reasons are propelling the growth of the advanced semiconductor packaging market throughout the region.